How does EUnetHTA make a difference in national and regional HTA processes? Is industry seeing an evolution in interaction between HTAs and regulators? What are the EUnetHTA JA2 Recommendations (endorsed by the EUnetHTA Plenary Assembly) on sustainable European cooperation on HTA? Where are synergies between regulation, HTA, policy and reimbursement decision-making that will benefit European patients?
The European Commission’s President-elect has appointed Mr. Vytenis P. Andriukaitis (Lithuanian) and Ms Elżbieta Bieńkowska (Poland) as the new Commissioners for 'Health and Food Safety' and 'Internal Market, Industry, Entrepreneurship and SMEs' respectively.
EUnetHTA was established to create an effective and sustainable network for HTA across Europe – we work together to help developing reliable, timely, transparent and transferable information to contribute to HTAs in European countries.
EUnetHTA is a network of government appointed organisations (from EU Member States, EU-accession countries, plus EEA and EFTA countries) and a large number of relevant regional agencies and non-for-profit organisations that produce or contribute to HTA in Europe.
Methodological Guidelines for Rapid REA of Pharmaceuticals are guidelines on methodological challenges that are encountered by health technology assessors while performing a rapid relative effectiveness assessment of pharmaceuticals. The primary aim of the guidelines is to help the assessors of evidence interpret and process the data that are presented to them as part of a REA.
The aim of the Glossary of HTA Adaptation Terms is to identify and highlight key words and concepts that are easily misunderstood between countries with a view to aiding the adaptation of HTA reports between settings. It provides a series of descriptions for such terms and contains examples of where the usage of these terms may differ between countries.
The EUnetHTA Stakeholder Forum is formed to ensure a transparent engagement with a broad range of stakeholders and is comprised of representatives from patient and healthcare consumer organisations, healthcare providers, payers (statutory health insurance) and the industry. The Stakeholder Forum's composition aims at ensuring broad and balanced representation of stakeholder interests.
Under "contact us", you will find a list of all Stakeholder members with an indication of which group they belong to in parenthesis.
Organisations representing interests of four stakeholder groups – patients/consumers, industry, payers (statutory health insurance) and healthcare providers can participate via the EUnetHTA Stakeholder Forum.
Public Consultations are held regularly as a form of soliciting public input on the draft documents produced by EUnetHTA within the framework of implementing the EUnetHTA Joint Action 2 grant agreement and 3-year EUnetHTA Joint Action 2 Work Plan.
Announcements of the public consultations are made in the "News" section of this website.
The full list of public consultations (ongoing or closed) is available in the "Get involved" section of this website